Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ABBV

Recent news which mentions ABBV

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.
Tickers ABBV ABT MDT PFE
Tags PFE Market News Recent Press Releases
From Motley Fool
Why Cerevel Therapeutics Holdings Is Moving After-Hours
Tickers ABBV CERE
Tags News why it's moving Movers
From Benzinga
AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal
Tickers ABBV CERE
Tags ABBV CERE
From MarketWatch
7 High-Dividend Stocks to Buy for a Lifetime of Passive Income
Tickers ABBV EPD IIPR PSA
Tags ABBV TSN WSO
From InvestorPlace
Small Cap, Big Potential: 3 Russell 2000 Stocks to Watch
Tickers ABBV DASH DUOL IMGN
Tags Stocks to Buy DASH Market News
From InvestorPlace
Decoding AbbVie's Options Activity: What's the Big Picture?
Tickers ABBV
Tags Market News BZI/UOA Markets
From Benzinga
ImmunoGen, AbbVie's $10B Deal Comes At 'Right Time' Analyst Says In Downgrade Note
Tickers ABBV IMGN
Tags News Price Target M&A
From Benzinga
2 Dividend Stocks to Buy and Hold Forever
Tickers ABBV V
Tags ABBV V Recent Press Releases
From Motley Fool
5 S&P 500 Stocks That Pay a Generous Dividend
Tickers ABBV MO PM T
Tags PM Market News T
From Motley Fool
Analyst Ratings for AbbVie
Tickers ABBV
Tags Analyst Ratings Market News Benzinga
From Benzinga
Why Abbvie Stock Popped Today
Tickers ABBV IMGN
Tags Recent Press Releases ABBV IMGN
From Motley Fool
ImmunoGen's Flagship Cancer Therapy Draws AbbVie's Attention With $10.1B Deal
Tickers ABBV IMGN
Tags IMGN M&A General
From Benzinga
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
Tickers ABBV HOOD IMGN RDHL
Tags ABBV HOOD RDHL
From InvestorPlace
Health Care Company AbbVie Announces Acquisition of Immunogen
Tickers ABBV IMGN
Tags Benzinga Trading Ideas IMGN
From Benzinga
AbbVie’s $10.1 billion deal to buy ImmunoGen values the stock at a 95% premium
Tickers ABBV IMGN SPX
Tags IMGN SPX ABBV
From MarketWatch
AbbVie Should Consider a Dividend Cut -- Here's Why
Tickers ABBV
Tags Market News ABBV Recent Press Releases
From Motley Fool
Mastering Market Trends: The 7 Best Blue-Chip Stocks for Today’s Economy
Tickers ABBV AXP CRM FVRR
Tags MMM MSFT WEWKQ
From InvestorPlace
AbbVie's Lung Cancer Study Shows Encouraging Clinical Benefits In Subtype Of Patients
Tickers ABBV
Tags Equities Large Cap Biotech
From Benzinga
Medtronic Stock: Bull vs. Bear
Tickers ABBV MDT
Tags Market News MDT ABBV
From Motley Fool
3 Rising Stars: Invest Now in Tomorrow’s Trillion-Dollar Companies
Tickers ABBV ASML TSM
Tags TSM NYSE:ABBV,NYSE:TSM,NASDAQ:ASML ABBV
From InvestorPlace
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
Tickers ABBV GILD LLY
Tags ABBV Recent Press Releases LLY
From Motley Fool
How Is The Market Feeling About AbbVie?
Tickers ABBV
Tags Trading Ideas Short Sellers Benzinga
From Benzinga
Could AbbVie Stock Help You Become a Millionaire?
Tickers ABBV
Tags Market News Recent Press Releases ABBV
From Motley Fool
3 "Boring" Stocks That Could Make You Rich
Tickers ABBV ARCC EPD
Tags ARCC Market News EPD
From Motley Fool
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
Tickers ABBV LLY PFE
Tags LLY PFE ABBV
From Motley Fool
Dual Powerhouses: 7 Dividend Stocks Marrying High Yield With High Growth
Tickers ABBV DUK KO PFE
Tags PFE DUK KO
From InvestorPlace
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.